Article

Quadriceps strength protects against cartilage loss in knee osteoarthritis

Greater quadriceps strength protects against cartilage loss at the lateral compartment of the patellofemoral joint in persons with knee osteoarthritis (OA), and persons with greater quadriceps strength are likely to have less knee pain and better physical function. Greater quadriceps strength has no influence on cartilage loss at the tibiofemoral joint.

Greater quadriceps strength protects against cartilage loss at the lateral compartment of the patellofemoral joint in persons with knee osteoarthritis (OA), and persons with greater quadriceps strength are likely to have less knee pain and better physical function. Greater quadriceps strength has no influence on cartilage loss at the tibiofemoral joint.

Amin and associates evaluated 265 persons in a 30-month natural history study of knee OA. Cartilage morphology was scored using MRI at baseline and at 15 and 30 months, and baseline quadriceps strength was measured isokinetically for each leg. Long-limb films were used to evaluate alignment at the knee. Knee pain and physical function were assessed.

No association between quadriceps strength and cartilage loss was found in the medial or lateral tibiofemoral joint compartment or in the medial patellofemoral compartment, even in malaligned knees. However, stronger quadriceps protected against cartilage loss at the lateral compartment of the patellofemoral joint, a finding that needs confirmation. Participants in the highest tertile of quadriceps strength had significantly less knee pain and better physical function than those in the lowest tertile.

The authors noted that the focus of their study was on quadriceps strength and not on strengthening or exercise.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.